🔗 Share this article

Texas Attorney General Ken Paxton is taking legal action against the manufacturers of acetaminophen, asserting the corporations withheld alleged dangers that the pain reliever posed to pediatric cognitive development.

The court filing arrives thirty days after Former President Trump advocated an unproven link between using Tylenol - referred to as acetaminophen - during pregnancy and autism in young ones.

Paxton is suing J&J, which once produced the drug, the sole analgesic approved for pregnant women, and the current manufacturer, which now manufacturers it.

In a declaration, he said they "misled consumers by gaining financially from discomfort and pushing pills ignoring the dangers."

The manufacturer states there is lacking scientific proof connecting acetaminophen to autism spectrum disorder.

"These manufacturers deceived for years, deliberately risking millions to line their pockets," the attorney general, a Republican, said.

Kenvue commented that it was "very worried by the perpetuation of misinformation on the security of acetaminophen and the possible consequences that could have on the health of US mothers and children."

On its official site, Kenvue also said it had "regularly reviewed the relevant science and there is lacking reliable evidence that demonstrates a proven link between using acetaminophen and autism spectrum disorder."

Groups acting on behalf of medical professionals and medical practitioners concur.

The leading OB-GYN organization has declared paracetamol - the primary component in acetaminophen - is among limited choices for pregnant women to address pain and fever, which can present significant medical dangers if not addressed.

"In more than two decades of studies on the consumption of paracetamol in pregnancy, not a single reputable study has successfully concluded that the use of acetaminophen in any period of gestation causes neurological conditions in young ones," the group commented.

The court filing references current declarations from the former administration in asserting the medication is reportedly hazardous.

Last month, the former president raised alarms from health experts when he told pregnant women to "resist strongly" not to use Tylenol when unwell.

The FDA then released a statement that doctors should think about restricting the usage of Tylenol, while also stating that "a proven link" between the drug and autism in children has remains unverified.

The Health Department head Robert F Kennedy Jr, who manages the Food and Drug Administration, had vowed in spring to initiate "a massive testing and research effort" that would establish the origin of autism spectrum disorder in a matter of months.

But experts advised that finding a single cause of autism - thought by researchers to be the outcome of a complex mix of inherited and surrounding conditions - would not be simple.

Autism spectrum disorder is a category of enduring cognitive variation and impairment that impacts how people perceive and engage with the world, and is diagnosed using physician assessments.

In his legal document, the attorney general - who supports Trump who is campaigning for US Senate - claims the manufacturer and J&J "intentionally overlooked and tried to quiet the research" around paracetamol and autism.

The lawsuit aims to force the firms "destroy any promotional materials" that states Tylenol is reliable for expectant mothers.

This legal action echoes the complaints of a collection of mothers and fathers of minors with autism and ADHD who filed suit against the producers of Tylenol in recently.

A federal judge dismissed the legal action, declaring research from the parents' expert witnesses was not conclusive.